Healthcare Equipment and Supplies
Company Overview of Quanta BioDesign, Ltd.
Quanta BioDesign, Ltd. researches and develops discrete polyethylene glycol pegylation reagents. The company offers payload delivery, chemical modification, crosslinking reagents, biotinylation, and peptide modification reagents. It markets products under the dPEG brand name. Quanta BioDesign, Ltd. was formerly known as BioOrganic Technologies, LLC and changed its name to Quanta BioDesign, Ltd. in 1999. The company was founded in 1997 and is based in Plain City, Ohio.
7470 Montgomery Drive
Plain City, OH 43064
Founded in 1997
Key Executives for Quanta BioDesign, Ltd.
Quanta BioDesign, Ltd. does not have any Key Executives recorded.
Similar Private Companies By Industry
|.decimal, Inc.||United States|
|20/20 GeneSystems Inc.||United States|
|20/20 Imaging LLC||United States|
|21st Century Scientific, Inc.||United States|
|21X Corporation||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
To contact Quanta BioDesign, Ltd., please visit www.quantabiodesign.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.